Outcomes and Toxicities of Programmed Death‐1 (PD‐1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Real‐World, Multicenter Retrospective Analysis
Keyword(s):
Keyword(s):
2016 ◽
Vol 111
◽
pp. S324
◽
Keyword(s):
Keyword(s):
Keyword(s):
2019 ◽
Keyword(s):
Keyword(s):
Keyword(s):